Paradoxically, Plisiecka-Hałasa et al. found that c-MYC overexpression was associated with better tumor differentiation, higher p27, and lower Ki-67 expression in ovarian carcinomas treated with platinum-based regimens (70). This evidence concerns the gene MYC and neoplasm.